| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971196 | The Journal of Heart and Lung Transplantation | 2010 | 8 Pages |
Abstract
Pre-treatment by intravenous injection of colV inhibits bleomycin-induced pulmonary fibrosis by inhibiting IL-6 and IL-17 production. Fibrosis treatment in this context therefore should target induction of colV tolerance and Th17 development.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ruedi K. PhD, Alicia MS, Shivanee PhD, Makio PhD, Melissa MS, Kathryn BS, Periannan MD, Christopher H. MD, David D. PhD, Robert B. MD,